1. services
  2. pharmacokinetic testing services

Proteomics -Pharmacokinetic Testing Services

SHARE

Comprehensive suite of new pre-clinical and clinical testing capabilities: pharmacokinetic (PK), pharmacodynamic (PD), and companion diagnostic (CDx) services. Proteomics International applies its proven expertise and experience in targeted mass spectrometry to the field of PK testing. Mass spectrometry is ideal for the accurate and precise quantitation of target drugs and their break-down products in biological matrices, the basis of pharmacokinetic testing. Our workflows are capable of handling varying sample types including plasma, whole blood and urine. Proteomics International’s high-throughput analytical capabilities, using state of the art LC-MS spectrometers and liquid handling robots, ensures that it is able to analyse a range of small molecule, large molecule, and peptide drugs in an automated manner, yielding efficient and accurate analysis.

Most popular related searches
  • Pre-clinical and clinical analytical services.
  • Method development of quantitative assays for drugs in biological matrices using industry standard LC-MS/MS systems.
  • Method development and validation is conducted in accordance with international recognised regulatory standards.
  • Sample testing and reporting utilises validated software

Quality Guarantee

Proteomics International stands behind the quality, timeliness and reliability of its services. If results are not delivered on time and do not comply with international recognised regulatory standards, charges may not apply.

Accreditations

Proteomics International is ISO/IEC 17025 accredited and operates in accordance with the OECD Principles of Good Laboratory Practice (GLP).

Quick results

Proteomics International delivers quick and accurate pharmacokinetic results, with the ability to deliver results within three days of receiving samples upon request.

R&D Tax Incentive

The Australian Government’s Research & Development Tax Incentive offers significant benefits to carrying out research in Australia. Eligible companies could recover as much as 43.5% of every dollar spent on research and development.

Proteomics International can refer you to tax advisors who can facilitate simple and cost-effective access to the R&D Tax Incentive.

Projects successfully undertaken include:

  • Amphotericin B
  • Dopamine
  • Dutasteride
  • Entecavir
  • Gliclazide